tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alex Schwartz, 15 are a BUY (100%).
Analyst Alex Schwartz, carries an average stock price target met ratio of 50% that have a potential upside of 35.97% achieved within 557 days. Previously, Alex Schwartz worked at STIFEL.
Alex Schwartz’s has documented 27 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANAB, AnaptysBio at 21-Feb-2024.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for MNTA (MOMENTA PHARMACEUTICALS) at 1/5/2018. The price target of $15 was fulfilled within 4 days with a profit of $2.55 (14.53%) receiving and performance score of 36.32.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 10-Mar-2022
3 months 25 days ago
(19-Sep-2025)
0/2 (0%)
$16.92 (333.07%)
Buy
Since 10-Dec-2021
$4
$0.12 (3.09%)
8 months 6 days ago
(07-May-2025)
1/12 (8.33%)
$3.13 (359.77%)
205
Hold
Since 18-Dec-2024
$3
$-0.88 (-22.68%)
$4
8 months 27 days ago
(17-Apr-2025)
10/10 (100%)
$2.05 (215.79%)
115
Buy
Since 11-Nov-2015
$4
$0.12 (3.09%)
10 months 8 days ago
(05-Mar-2025)
2/12 (16.67%)
$2.35 (142.42%)
262
Buy
Since 06-Mar-2023
$4
$0.12 (3.09%)
$7
11 months 2 days ago
(11-Feb-2025)
1/3 (33.33%)
$2.21 (123.46%)
290
What Year was the first public recommendation made by Alex Schwartz?
